Pembrolizumab-Induced Diabetic Ketoacidosis: A Review of Critical Care Case
Author:
Publisher
Cureus, Inc.
Subject
Aerospace Engineering
Reference10 articles.
1. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis;Wang DY;JAMA Oncol,2018
2. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project;Ladewski LA;J Clin Oncol,2003
3. Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab;Eun Y;Sci Rep,2019
4. Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis;Baxi S;BMJ,2018
5. Pembrolizumab (Keytruda);Kwok G;Hum Vaccin Immunother,2016
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune-Mediated Diabetes Mellitus, Diabetic Ketoacidosis, Enteritis, and Thrombotic Thrombocytopenic Purpura Presenting as Adverse Effects of Pembrolizumab Therapy;American Journal of Therapeutics;2024-07
2. Autoimmune diabetes from pembrolizumab: A case report and review of literature;World Journal of Clinical Oncology;2023-11-24
3. A Case of Pembrolizumab-Induced Diabetic Ketoacidosis and Hyperthyroidism in a Patient With Recurrent Esophageal Adenocarcinoma;Cureus;2023-02-21
4. PD-1 inhibitor-associated type 1 diabetes: A case report and systematic review;Frontiers in Public Health;2022-08-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3